Abstract
Until now, many researchers have explained the degradation rate of biodegradable scaffold with respect to several parameters such as porosity, pore size, and strand diameter. In this study, to analyze the degradation rate of Polycaprolactone (PCL) scaffold, accelerated degradation experiment using sodium hydroxide (NaOH) was used. For the experiment, PCL scaffolds were fabricated by bioplotter with respect to porosity, pore size, and strand diameter, respectively. Each fabricated scaffold was put into a vial filled with 5 mol-NaOH 5 mL and trapped-air was removed using vacuum desiccator. After that, all vials were placed in the waterbath which was maintained with 37°C For 24 days, seven vials were taken out from the waterbath for every 2 days and each scaffold was dried after rinsing with D.I. water. Afterwards, the degradation rate was analyzed for each type of PCL scaffolds using the measured mass. Among them, one type of scaffolds, which has the strand diameter of 300 μm and the pitch between strands of 800 μm, was used for the measurement of molecular weight change via gel permission chromatography (GPC). To show the each conventional parameter could not explain alone the degradation rate, the calculated degradation rates were analyzed with respect to porosity, pore size, and strand diameter, respectively. Afterwards, every degradation rate of all types of scaffolds was recorded with respect to the dimensionless surface area which is surface area/ S0. S0 is the surface area of sphere which has same volume of respective scaffold. Consequently, the dimensionless surface area was found to be a single parameter irrelevant to the type of PCL scaffold to explain the in-vitro degradation rate of accelerated NaOH experiment.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
E Sachlos and JT Czernuszka, Making tissue engineering scaffolds work. review on the application of solid freeform fabrication technology to the production of tissue engineering scaffolds, European Cells Mater, 5, 29 (2003).
P Zhang, Z Hong, T Yu, X Chen, X Jing, In vivo mineralization and osteogenesis of nanocomposite scaffold of poly(lactide-co-glycolide) and hydroxyapatite surface-grafted with poly(L-lactide), Biomaterials, 30, 58 (2009).
AS Rowlands, SA Lim, D Martin, JJ Cooper-White, Polyurethane/poly(lactic-co-glycolic) acid composite scaffolds fabricated by thermally induced phase separation, Biomaterials, 28, 2107 (2007).
M-O Montjovent, L Mathieu, H Schmoekel, S Mark, P-E Bourban, P-Y Zambelli, LA Laurent-Applegate, DP Pioletti, Repair of critical size defects in the rat cranium using ceramicreinforced PLA scaffolds obtained by supercritical gas foaming, J Biomed Mater Res A, 83A, 41 (2007).
HW Kang, Y Tabata, Y Ikada, Fabrication of porous gelatin scaffolds for tissue engineering, Biomaterials, 20, 1339 (1999).
H Seitz, W Rieder, S Irsen, B Leukers, C Tille, Threedimensional printing of porous ceramic scaffolds for bone tissue engineering, J Biomed Mater Res B: Appl Biomater, 74B, 782 (2005).
KH Lee, GH Jin, CH Jang, W-K Jung, GH Kim, Preparation and characterization of multi-layered poly(-caprolactone)/chitosan scaffolds fabricated with a combination of meltplotting/in situ plasma treatment and a coating method for hard tissue regeneration, J Mater Chem B, 1, 5831 (2013).
YB Kim, GH Kim, Collagen/alginate scaffolds comprising core (PCL)-shell (collagen/alginate) struts for hard tissue regeneration: fabrication, characterisation, and cellular activities, J Mater Chem B, 1, 3185 (2013).
JM Williams, A Adewunmi, RM Schek, CL Flanagan, PH Krebsbach, SE Feinberg, SJ Hollister, S Das, Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering, Biomaterials, 26, 4817 (2005).
FPW Melchels, AMC Barradas, CA van Blitterswijk, J de Boer, J Feijen, DW Grijpma, Effects of the architecture of tissue engineering scaffolds on cell seeding and culturing, Acta Biomaterialia, 6, 4208 (2010).
T Hayashi, Biodegradable polymers for biomedical uses, Prog Polym Sci, 19, 663 (1994).
H Sun, L Mei, C Song, X Cui, P Wang, The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials, 27, 1735 (2006).
J-H Shim, T-S Moon, M-J Yun, Y-C Jeon, C-M Jeong, D-W Cho, J-B Huh, J Mater Sci: Mater Med, 23, 2993 (2012).
CXF Lam, MM Savalani, S-H Teoh, DW Hutmacher, Dynamics of in vitro polymer degradation of polycaprolactonebased scaffolds: accelerated versus simulated physiological conditions, Biomed mater, 3, 1 (2008).
L Wu, J Ding, Effects of porosity and pore size on in vitro degradation of three-dimensional porous poly(D,L-lactide-coglycolide) scaffolds for tissue engineering, J Biomed Mater Res A, 75A, 767 (2005).
SI Jeong, B-S Kim, YM Lee, KJ Ihn, SH Kim, YH Kim, Morphology of Elastic Poly(L-lactide-co—caprolactone) Copolymers and in Vitro and in Vivo Degradation Behavior of Their Scaffolds, Biomacromolecules, 5, 1303 (2004).
H-J Sung, C Meredith, C Johnson, ZS. Galis, The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis, Biomaterials, 25, 5735 (2004).
JJ Yoon, TG Park, Degradation behaviors of biodegradable macroporous scaffolds prepared by gas foaming of effervescent salts, J Biomed Mater Res, 55, 401 (2000).
A Yeo, B Rai, E Sju, JJ Cheong, SH Teoh, The degradation profile of nevel, bioresorbable PCL-TCP scaffolds: An in vitro and in vivo study. J Biomed Mater Res A, 84A, 208 (2007).
CM Agrawal, JS McKinney, D Lanctot, KA Athanasiou, Effects of fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for tissue engineering, Biomaterials, 21, 2443 (2000).
W-J Lin, DR Flanagan, RJ Linhardt, Accelerated Degradation of Poly(epsilon-caprolactone) by Organic Amines, pharmaceutical research, 11, 1030 (1994).
U Little, F Buchanan, E Harkin-Jones, M McCaigue, D Farrar, G Dickson, Accelerated degradation behaviour of poly(3- caprolactone) via melt blending with poly(aspartic acid-colactide) (PAL), Polym Degrad Stabil, 94, 213 (2009).
CG Pitt, FI Chasalow, YM Hibionada, DM Klimas, A Schindler, Aliphatic polyesters. 1. The degradation of poly(epsilon-caprolactone) in vivo, J Appl Polym Sci, 26, 3779 (1981).
M Therin, P Christel, S Li, H Garreau, M Vert, In vivo degradation of massive poly(alpha-hydroxyacids) validation of in vitro findings, Biomaterials, 13, 594 (1992).
AS Htay, SH Teoh, DW Hutmacher, Development of perforated microthin poly(epsilon-caprolactone) films as matrices for membrane tissue engineering, J Biomater Sci Polym Ed, 15, 683 (2004).
YC Kim, HS Jun, HN Chang, SI Woo, Optimal Conditions for Enzymatic Degradation of Polycaprolactone, J Korean Chem Eng Res, 30, 718 (1992).
MA Woodruff, DW Hutmacher, The return of a forgotten polymer-Polycaprolactone in the 21st century, Prog Polym Sci, 35, 1217 (2010).
AS Htay, SH Teoh, DW Hutmacher, Development of perforated microthin poly (ε-caprolactone) films as matrices for membrane tissue engineering, J. Biomater. Sci. Polymer Edn, 15, 683 (2004).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lee, SH., Lee, J.H. & Cho, YS. Analysis of degradation rate for dimensionless surface area of well-interconnected PCL scaffold via in-vitro accelerated degradation experiment. Tissue Eng Regen Med 11, 446–452 (2014). https://doi.org/10.1007/s13770-014-0067-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13770-014-0067-y